Anti-platelet aggregating and disaggregating activities of 6,9-methano PGI2.
D000818:Animals; D011464:Epoprostenol / Q000494:pharmacology* / Q000031:analogs & derivatives; D006801:Humans; D066298:In Vitro Techniques; D010974:Platelet Aggregation / Q000187:drug effects*; D011453:Prostaglandins / Q000494:pharmacology*; D011458:Prostaglandins E / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D013806:Theophylline / Q000494:pharmacology
D011453:Prostaglandins; D011458:Prostaglandins E; C026678:carboprostacyclin; D013806:Theophylline; D011464:Epoprostenol